drugset

drugset / Trial / NCT06015269

Exploratory Study on Baize DC Injection in Preventing Recurrence and Metastasis After Radical Tumor Surgery

NCT06015269 ↗

Phase 1 Unknown 200 enrolled Shanghai Cell Therapy Group Co.,Ltd

NaSingle-groupOpen-labelPrevention

Summary

This is an exploratory study on the safety, immune response, and preliminary effectiveness of single arm, fixed dose therapy

Timeline

Start: 2023-08
Primary completion: 2025-07
Completion: 2025-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	DC cells	Cell therapy	1e+07 cells	—

Indications